December 16, 2025 Tampa, FL– Hyde Park Capital is pleased to announce that it has been honored with two awards at the 24th Annual M&A Advisor Awards. The firm received the USA Healthcare Deal of the Year award for its role as financial advisor on the strategic partnership between Surgery Partners and eleven Wisconsin based physician-owned entities, and the USA Growth Investment Deal of the Year award for its role as financial advisor on RF Investment Partners’ majority investment in Valley Infusion and Home Infusion.
Earlier this year, Hyde Park Capital was named a finalist in seven M&A Advisor Awards categories, spanning healthcare, industrials, corporate and strategic, and professional firm recognitions. Winners were announced at the Awards Gala, held during the 2025 Future of Dealmaking Summit on Wednesday, November 19, 2025, at the New York Athletic Club in New York City.
The event welcomed more than 500 industry leaders to recognize top achievements, underscoring M&A’s collaborative nature and its role in driving innovation and growth. Hyde Park Capital was represented at the Awards Gala by Craig Lawson, Managing Director at Hyde Park Capital.
The USA Healthcare Deal of the Year award recognizes Hyde Park Capital’s advisory role in the strategic partnership between Surgery Partners and eleven Wisconsin based physician-owned entities to form Midwest Orthopedic and Musculoskeletal Alliance (MOMA). The Hyde Park Capital deal team included Josh Paul, Director, Joe Pennington, Senior Vice President, and Jake Arnoys, Associate.
Additional information about this transaction is available in Hyde Park Capital’s press release here: https://www.hydeparkcapital.com/insights/press-releases/hyde-park-capital-advises-eleven-physician-owned-entities-in-their-strategic-partnership-with-surgery-partners-to-form-midwest-orthopedic-and-musculoskeletal-alliance-moma/
The USA Growth Investment Deal of the Year award recognizes Hyde Park Capital’s advisory role in RF Investment Partners’ majority investment in Valley Infusion and Home Infusion. The deal team was led by Michael Johnson, Managing Director at Hyde Park Capital.
Additional information about this transaction is available in Hyde Park Capital’s press release here: https://www.hydeparkcapital.com/insights/press-releases/hyde-park-capital-advises-rf-investment-partners-on-its-recent-majority-investment-in-valley-vital-valley-infusion-home-infusion-richmond/
“For nearly three decades, The M&A Advisor has been honoring the leading M&A transactions, companies and dealmakers. Hyde Park Capital was chosen from hundreds of participating companies to become an awards winner. It gives us great pleasure to recognize Hyde Park Capital as winners for mergers and acquisitions firms and professionals”, said Roger Aguinaldo, Founder and CEO of The M&A Advisor. “Hyde Park Capital represents the best of the industry in 2024-25 and earned these finalist honors by standing out in a group of very impressive candidates.”
“We are grateful to Roger and the M&A Advisor for this prestigious recognition. These awards reflect the hard work and expertise of our team in executing complex M&A transactions in both healthcare and growth investment markets,” said John Hill Jr., Managing Partner of Hyde Park Capital.
The 24th Annual M&A Advisor Awards were presented as part of the 2025 Future of Dealmaking Summit, which brought together more than 350 leading professionals for interactive forums, roundtable discussions, one-on-one meetings and a solutions provider showcase led by M&A industry leaders and business media experts.
About The M&A Advisor
Now in its 27th year, The M&A Advisor was founded to offer insights and intelligence on mergers and acquisitions, establishing the industry’s leading media outlet in 1998. Today, the firm is recognized as the world’s premier leadership organization for mergers & acquisition, restructuring and corporate finance professionals, delivering a range of integrated services, including the most active online community of M&A professionals called M&A Connects. www.maadvisor.com.
About Hyde Park Capital
Hyde Park Capital is a nationally recognized boutique investment banking firm specializing in mergers and acquisitions and capital raising, primarily for successful founder and family-owned companies located across the country. Hyde Park Capital’s principals have extensive investment banking experience, including managing sell-side and buy-side transactions, recapitalizations, financial advisory assignments, fairness opinions, raising growth and acquisition capital for companies, including equity, mezzanine, senior debt, and project finance. Our industry sector focus includes healthcare, technology, business, industrial services, and consumer.
Hyde Park Capital is headquartered in Tampa, Florida, with additional offices in Nashville, Tennessee, and San Francisco, California, and is a member of FINRA and SIPC. For additional information, please visit www.hydeparkcapital.com.
Media Contact
Rebecca Puhalovich (Formerly Stapp)
Marketing Manager
Hyde Park Capital
Puhalovich@hydeparkcapital.com
(813) 868-5734